SEP 24, 2018 10:01 PM PDT

Protein Serves as a Potential Drug Target

WRITTEN BY: Nouran Amin

Image via Phys.org

Researchers at Van Andel Research Institute (VARI) have shown an atomic-level structure of a protein that may serve as a future drug target for conditions like Alzheimer's disease and bipolar disorder.

The protein, known as TRPM2, was found throughout the body to integrally be involved in body temperature regulation, immune response mediation, and governing the programmed death of cells (apoptosis).

TRPM2 belongs to the TRP superfamily of proteins that work to mediate responses to sensory stimuli, inclduing pain, pressure, vision, temperature and taste.

"TRPM2 is absolutely critical for healthy function but, until today, we were missing key insights into its structure and mechanism of action," says Juan Du, Ph.D., an assistant professor at VARI. "It is our hope that these findings will act as a schematic for designing better and desperately needed medications for a host of neurological conditions." It is now the first protein to be pictured at the atomic level.

Image via Drug Target Review

The images of TRPM2 on the atomic level have illustrated a “bell-like structure, with a transmembrane domain region on the bell's shoulder and an expanded NUDT9-H domain on the bell's lip”. Images also revela the bindg site for ADPR, the messenger molecule associated with oxidative stress and metabolism. "Although we have known for some time that TRPM2 is a vital component of many biological processes and a possible drug target, we didn't know exactly what it looked like or how it worked," said Wei Lü, Ph.D., an assistant professor at VARI and co-senior author. "Today's findings change that, and go a long way toward a more comprehensive understanding of these incredibly important molecules."

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 14, 2018
Drug Discovery
AUG 14, 2018
Anticancer Drugs Help Plants Fight Infection
Drugs used for cancer treatments may now help plants fight diseases. A study conducted at Washington State University (WSU), by two plant pathologists&mdas...
AUG 27, 2018
Drug Discovery
AUG 27, 2018
Anemic Drug Re-purposed To Treat Heart Failure in Diabetics
According to a study funded by the British Heart Foundation (BHF) and Diabetes UK, drugs in development to treat anemia can now be repurposed to help preve...
NOV 05, 2018
Drug Discovery
NOV 05, 2018
Drug Combination Halts The Progression of Fibrosis
After seven years of research, scientists at Anglia Ruskin University, University College London and KU Leuven—developed a drug combination that hold...
NOV 13, 2018
Drug Discovery
NOV 13, 2018
Clinical Trial Drug For a Rare Neurodegenrative Disease Proven Unsuccessful
Niemann-Pick type C (NPC) is a rare and fatal neurodegenerative disease. Symptoms of the condition include loss of balance, difficulty swallowing, seizures...
NOV 25, 2018
Drug Discovery
NOV 25, 2018
Advancing Drug Therapies for an Increasing Case of a Parasitic infection Among Displaced Syrians
Cases of Cutaneous leishmaniasis (CL), a parasitic disease, has increased dramatically in Syria and neighboring countries as a result of the conflict-relat...
DEC 04, 2018
Drug Discovery
DEC 04, 2018
Drug Combination May Be Effective for Melanoma
Protein kinase inhibitors have been noted to be the most effective class of drugs in the treatment of melanoma—a deadly skin cancer of the melanocyte...
Loading Comments...